InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,180.00
(
1.17%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.19
(
-1.27%
)
Bitcoin
61,753.18
(
2.47%
)
Post# of 252347
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119916
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Mufaso post# 250577

Wednesday, 04/24/2024 5:27:57 PM

Wednesday, April 24, 2024 5:27:57 PM

Post# of 252347

VKTX—Not sure why they wouldn't have a normal end of phase-2 meeting with FDA on the obesity drug.

Based on today’s 1Q24 CC Q&A session, it seems that VKTX wants a type-C meeting with the FDA regarding VK2735 to ascertain whether they can proceed directly to phase-3 without running a phase-2b.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up